Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer

Virchows Archiv

Volumn 431, Issue 6, 1997, Pages 375-381

  Lisboa, Björn W ^a   Vogtländer, Sabine ^a   Gilster, Tobias ^a   Riethdorf, Lutz ^a   Milde Langosch, Karin ^a   Löning, Thomas ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Breast cancer; Immunohistochemistry; p53 mutation; Protein p53; Temperature gradient gel electrophoresis (TGGE)

Indexed keywords

HORMONE RECEPTOR; PARAFFIN; PROTEIN P53; TISSUE EXTRACT;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DUCT; BREAST HYPERPLASIA; BREAST LESION; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CARCINOMA IN SITU; COMEDO; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; EXON; FEMALE; FROZEN SECTION; GEL ELECTROPHORESIS; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; STATISTICAL ANALYSIS; TISSUE PREPARATION; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030696919     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050114     Document Type: Article

References (38)

1. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negativ breast cancer. J Natl Cancer Inst 85:200-206
2. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL (1993) Prognostic significance of TP53 alteration in breast cancer. Br J Cancer 68:540-548
3. Barbareschi M, Caffo O, Veronese S, Leek RD, Fina P, Fox S, Bonzanini M, Girlando S, Morelli L, Eccher C, Pezzella F, Doglioni C, Dalla Palma P, Harris A (1996) Bcl-2 and p53 expression in node-negative breast carcinoma. Hum Pathol 27: 1149-1155
4. Bártek J, Bártková J, Vojtesek B, Stasková Z, Rejthar A, Kovarik J, Lane DP (1990) Patterns of expression of the p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int J Cancer 46:839-844
5. Bártek J, Bártková J, Voijtesek B (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699-1703
6. Beck JS, Kwitek AE, Cogen PH, Metzger AK, Duyk GM, Sheffield VC (1993) A denaturing-gradient gel-electrophoresis assay for sensitive detection of p53 mutations. Hum Genet 91:25-30
7. Caron de Fromentel C, Soussi T (1992) TP53 Tumor suppressor gene: a model for investigating human mutagenesis. Genes, Chromosom Cancer 4:1-15
8. Chromczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid-guanidinium-thiocyanate-phenol-chloroform extraction. Ann Biochem 162:156-159
9. Davidoff AM, Kerns BJM, Iglehart D, Marks JR (1991) Maintenance of p53 alterations throughout breast cancer progression. Cancer Res 51:2605-2610
10. Dunn JM, Hastrich DJ, Newcomb P, Webb JC, Maitland NJ Farndon JR (1993) Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg 80:1410-1402
11. Dupont WD, Page DL (1985) Risk factors for breast cancer in woman with proliferative breast disease. N Engl J Med 312: 146-151
12. Eeles RA, Warren W, Knee G, Bartek J, Averill D, Stratton MR, Blake PR, Tait DM, Lane DP (1993) Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogene 8:1269-1276
13. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF 1, a potential mediator of p53 tumor suppression. Cell 75:817-825
14. Fisher CJ, Gillett CE, Vojtesek B, Barnes DM, Millis RR (1994) Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. Br J Cancer 69:26-31
15. Fodde R, Losekoot M (1994) Mutation detection by denaturing gel electrophoresis (DGGE) Hum Mutat 3:83-94
16. Gudas JM, Oka M, Diella F, Trepel J, Cowan KH (1994) Expression of wild-type p53 during the cell cycle in normal human mammary epithelial cells. Cell Growth Differ 5:295-304
17. Hall PA, McKee PH, Menage H du P, Dover R, Lane DP (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203-207
18. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 Mutations in human cancers. Science 253:49-53
19. Hurlimann J, Chaubert P, Benhatter J (1994) p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Mod Pathol 7:423-428
20. Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Röhlke P, Löning T (1995) p53 Mutations in ovarian tumors, detected by Temperature- gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer 64:52-59
21. Kastan MB, Zhan Q, El-Deiry WS, Carries F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597
22. Kern S, Kinzler KW, Bruskin A, Jarosz D, Friedmann P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence specific DNA binding protein. Science 252:1708-1711
23. Kiene P, Milde-Langosch K, Runkel M, Schulz K, Löning T (1992) A simple and rapid technique to process formalin-fixed, paraffin-embedded tissues for the detection of viruses by polymerase chain reaction. Virchows Arch [A] 420: 269-273
24. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell-cycle checkpoint determinant following irradiatio. Proc Natl Acad Sci USA 89:7491-7495
25. Lane DP (1992) p53, guardian of the genome. Nature 358: 15-16
26. Lohmann D, Ruhri Ch, Schmitt M, Graeff H, Höfler H (1993) Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Diagn Mol Pathol 2:36-41
27. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Löning T (1995) The pathogenetic impact of HPV infection and p53 mutation differs in cancer of cervix uteri and the vulva. Int J Cancer 63:639-645
28. Milner J, Medcalf EA (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65:765-774
29. O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL (1994) p53 Mutations are confined to the comedo type ductal carcinoma in situ of the breast. Lab Invest 71:67-72
30. Poller DN, Roberts EC, Bell JA, Elston CW, Blamey RW, Ellis IO (1993) P53 protein expression in mammary ductal carcinoma in situ. Hum Pathol 24:463-468
31. Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S (1991) Mutations in p53 as potential molecular markers for muman breast cancer. Proc Natl Acad Sci USA 88:10657-10661
32. Scholz RB, Milde-Langosch K, Jung R, Schlechte H, Kabisch H, Wagener C, Löning T (1993) Rapid screening for Tp53 mutations by temperature-gradient gel electrophoresis: a comparison with SSCP analysis. Hum Mol Genet 2:2155-2158
33. Sheffield VC, Cox DR, Lerman LS, Myers RM (1989) Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci USA 86:232-236
34. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM (1992) p53 Allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer 50:528-532
35. Thor AD, Moore II DH, Edgerton SM, Kawasaki ES Reihsaus E, Lynch HT (1992) Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancer. J Natl Cancer Inst 84:845-854
36. Vojtesek B, Lane DP (1993) Regulation of p53 protein expression in human breast cancer cell lines. J Cell Sci 105:607-612
37. Walker RA, Dearing SJ, Lane DP, Varley JM (1991) Expression of p53 in infiltrating and in situ breast carcinomas. J Pathol (Lond) 165:203-211
38. Yonish RE, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347